Australian Pharma Stock News

Those following along with Telix Pharmaceuticals Limited ( ASX:TLX ) will no doubt be intrigued by the recent purchase...

South32 (ASX:S32) has flagged about US$1.1b in additional capital expenditure for the Taylor project at its Hermosa asset, taking total projected spend to roughly US$3.3b. First production has been pushed back from mid 2027 to mid 2028, with full capacity now targeted for FY2031, one year later than previously indicated. The update includes a 52% uplift in Ore Reserves, an extended mine life to around 33 years, and extra decline infrastructure aimed at improving long term operating...

Capricorn Metals recently reported its March quarter, highlighting strong cash flows from the Karlawinda Gold Project and declaring its first fully franked interim dividend, while confirming the Karlawinda expansion remains on schedule for commissioning in early FY27. This combination of record cash generation, improved cost efficiency and a shift toward regular shareholder distributions marks an important maturation point in Capricorn Metals’ business profile. We’ll now examine how...

Elsight Limited recently held its Q1 2026 earnings call on 29 April 2026, following news that shareholder activist Stephen Mayne had nominated himself for election as a non-executive director under Rule 14.3 of the company’s constitution, a move the board has urged investors to vote against at the 29 May 2026 AGM. This combination of an upcoming contested board vote and fresh quarterly results puts Elsight’s governance approach and execution under closer investor scrutiny. We’ll now examine...

IperionX recently shifted its Virginia facility to 24/7 continuous titanium production, advancing a government-backed push to build a domestic titanium supply chain for U.S. defense and industrial uses. This operational step, combined with fresh insider share purchases and long-dated equity awards, highlights management’s strong alignment with the company’s long-term titanium and critical minerals ambitions. We’ll now explore how the move to continuous titanium production shapes IperionX’s...

Woolworths Group (ASX:WOW) has revised its earnings outlook following its Q3 trading update. Management cited material cost pressures, including inflation and fuel price impacts, as key factors influencing the new guidance. The company flagged increasing competitive and regulatory headwinds in Australia and New Zealand, particularly affecting its New Zealand operations. Woolworths also highlighted geopolitical risks as a source of ongoing uncertainty for future profitability. Woolworths...

Appen recently reported a quarterly update showing around 9% revenue growth, driven by strong performance in its China segment, while its core Appen Global division continued to suffer from steep revenue declines and EBITDA losses. Despite the contrasting fortunes of China and Appen Global, management kept full-year guidance unchanged, which appears to have frustrated investors looking for clearer evidence of a sustained turnaround in group profitability. We’ll now examine how the guidance...

In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation. This milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...

Codan recently issued a major earnings upgrade and FY26 trading update, indicating FY26 EBIT is expected to be more than 60% higher than FY25 and that its Communications segment has reached a 30% profit margin target earlier than previously guided. This simultaneous outperformance in both defence-focused communications and Minelab’s metal detection products suggests Codan’s diversified technology portfolio is currently converting sector demand into higher-than-expected profitability. We’ll...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

In April 2026, APA Group completed a A$1.50 billion debt raise, including A$1.00 billion in hybrid subordinated capital securities and A$500 million in 6.42% senior unsecured notes due 2036, to support its stated growth plans. The strong investor demand for these fixed-income securities, with the issuances reportedly nearly four times oversubscribed, underlines fixed-income appetite for APA’s income-focused infrastructure profile. Now we’ll consider how this heavily oversubscribed A$1.50...

Suncorp Group Limited recently completed a Fixed-Income Offering, issuing A$200 million of Floating Rate Hybrid Notes that are convertible, non-cumulative and subordinated, with a variable coupon structure. This hybrid issuance adds a new layer to Suncorp’s capital structure, blending debt and equity characteristics that may influence how investors assess its funding mix and risk profile. We’ll now examine how Suncorp’s use of subordinated, floating rate hybrid capital could reshape its...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

With the business potentially at an important milestone, we thought we'd take a closer look at 6K Additive, Inc.'s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...

On 29 April 2026, Ramelius Resources reported its most profitable quarter to date, delivering a very large all-in sustaining cost margin despite revising cost guidance higher due partly to accounting changes and stronger gold prices. At the same time, the company accelerated its share buyback and advanced high‑grade discoveries at Dalgaranga, underlining management’s conviction in the business while industry‑wide diesel cost pressures continued to reshape its operating cost base. We’ll now...

Evolution Mining (ASX:EVN) has reported a significant uplift in its gold and copper resources, linked to recent exploration results and ongoing expansion studies. This has drawn fresh attention to the miner’s long term production profile. See our latest analysis for Evolution Mining. Despite the fresh resource update, Evolution Mining’s recent share price momentum has cooled, with a 30 day share price return of a 10.99% decline and a 90 day share price return of a 17.40% decline. This comes...

NEXTDC Limited recently completed a large-scale capital raising, including an A$750 million subordinated floating rate wholesale notes issue and an approximately A$1.51 billion rights-based follow-on equity offering, as part of its previously announced A$2.20 billion capital plan. These transactions lift NEXTDC’s pro forma liquidity to about A$6.60 billion and broaden its funding base as it pursues growth in Australia’s expanding data centre market. We’ll now examine how this expanded A$6.60...

Board refresh draws fresh attention to Aurelia Metals Aurelia Metals (ASX:AMI) has attracted fresh interest after announcing that Franklyn (Lyn) Brazil will rejoin its Board as a Non Executive Director, representing Brazil Farming Pty Ltd. Brazil brings prior Aurelia board experience, a background in agriculture and philanthropy, and a history of investing in ASX listed companies. Accounting and markets professional Bradley Newcombe will act as his alternate director. See our latest analysis...

Ora Banda Mining Ltd has appointed experienced mining executive John Richards as a non-executive director, effective 1 May 2026, with the board intending that he succeed outgoing chair Peter Mansell after the company’s 2026 annual general meeting in November. The leadership transition comes as Ora Banda reports strong operational performance, including high-grade gold intercepts at its Waihi project and record output from the Davyhurst gold operation, underscoring a period of operational...

As global markets navigate a complex landscape marked by record highs in major U.S. stock indexes, driven by robust economic data and AI-linked stocks, small-cap companies are capturing investor interest amid resilient consumer demand and evolving geopolitical tensions. In this environment, identifying promising small-cap stocks involves considering factors such as strong earnings potential and strategic insider actions that align with broader market trends.

If you are wondering whether James Hardie Industries at around A$29.10 is a bargain or just fairly priced, the next sections will walk through what the current share price might be implying. The stock has had a mixed run, with an 11.5% gain over the last 30 days, a 4.6% decline over the past week, and returns of 5.5% lower year to date and 21.8% lower over the last year. Recent coverage has focused on how these share price swings fit into the broader story for James Hardie Industries,...